Sarrazin C - Search Results

1

Future treatment of chronic hepatitis C with direct acting antivirals: is resistance important?

Halfon P, Sarrazin C. Halfon P, et al. Among authors: sarrazin c. Liver Int. 2012 Feb;32 Suppl 1:79-87. doi: 10.1111/j.1478-3231.2011.02716.x. Liver Int. 2012. PMID: 22212577 Review.

2

Ribavirin mode of action in chronic hepatitis C: from clinical use back to molecular mechanisms.

Hofmann WP, Herrmann E, Sarrazin C, Zeuzem S. Hofmann WP, et al. Among authors: sarrazin c. Liver Int. 2008 Dec;28(10):1332-43. doi: 10.1111/j.1478-3231.2008.01896.x. Liver Int. 2008. PMID: 19055642 Review.

3

How to use virological tools for the optimal management of chronic hepatitis C.

de Leuw P, Sarrazin C, Zeuzem S. de Leuw P, et al. Among authors: sarrazin c. Liver Int. 2011 Jan;31 Suppl 1:3-12. doi: 10.1111/j.1478-3231.2010.02398.x. Liver Int. 2011. PMID: 21205131

4

Resistance-associated substitutions in patients with chronic hepatitis C virus genotype 4 infection.

Dietz J, Kalinina OV, Vermehren J, Peiffer KH, Matschenz K, Buggisch P, Niederau C, Schattenberg JM, Müllhaupt B, Yerly S, Ringelhan M, Schmid RM, Antoni C, Müller T, Schulze Zur Wiesch J, Piecha F, Moradpour D, Deterding K, Wedemeyer H, Moreno C, Berg T, Berg CP, Zeuzem S, Welsch C, Sarrazin C; European HCV Resistance Study Group. Dietz J, et al. Among authors: sarrazin c. J Viral Hepat. 2020 Oct;27(10):974-986. doi: 10.1111/jvh.13322. Epub 2020 Jun 26. J Viral Hepat. 2020. PMID: 32396998

5

Hepatitis C virus-related resistance mechanisms to interferon alpha-based antiviral therapy.

Hofmann WP, Zeuzem S, Sarrazin C. Hofmann WP, et al. Among authors: sarrazin c. J Clin Virol. 2005 Feb;32(2):86-91. doi: 10.1016/j.jcv.2004.08.004. J Clin Virol. 2005. PMID: 15653410 Review.

6

Viral determinants of resistance to treatment in patients with hepatitis C.

Wohnsland A, Hofmann WP, Sarrazin C. Wohnsland A, et al. Among authors: sarrazin c. Clin Microbiol Rev. 2007 Jan;20(1):23-38. doi: 10.1128/CMR.00010-06. Clin Microbiol Rev. 2007. PMID: 17223621 Free PMC article. Review.

7

Resistance to direct antiviral agents in patients with hepatitis C virus infection.

Sarrazin C, Zeuzem S. Sarrazin C, et al. Gastroenterology. 2010 Feb;138(2):447-62. doi: 10.1053/j.gastro.2009.11.055. Epub 2009 Dec 16. Gastroenterology. 2010. PMID: 20006612 Review.

8

Current standards in the treatment of chronic hepatitis C.

Hofmann WP, Sarrazin C, Zeuzem S. Hofmann WP, et al. Among authors: sarrazin c. Dtsch Arztebl Int. 2012 May;109(19):352-8. doi: 10.3238/arztebl.2012.0352. Epub 2012 May 11. Dtsch Arztebl Int. 2012. PMID: 22675406 Free PMC article.

9

The role of resistance in HCV treatment.

Vermehren J, Sarrazin C. Vermehren J, et al. Among authors: sarrazin c. Best Pract Res Clin Gastroenterol. 2012 Aug;26(4):487-503. doi: 10.1016/j.bpg.2012.09.011. Best Pract Res Clin Gastroenterol. 2012. PMID: 23199507 Review.

10

The importance of HCV RNA measurement for tailoring treatment duration.

Peiffer KH, Sarrazin C. Peiffer KH, et al. Among authors: sarrazin c. Dig Liver Dis. 2013 Sep 30;45 Suppl 5:S323-31. doi: 10.1016/j.dld.2013.07.007. Dig Liver Dis. 2013. PMID: 24091111 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

417 results

Search Page